Facebook Linkedin RSS Twitter Youtube
Home 2024

Amyloid

Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients
Drug Discovery

Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients

Brain’s Waste Clearance Channels Mapped, Glymphatic Flows Confirmed
News

Brain’s Waste Clearance Channels Mapped, Glymphatic Flows Confirmed

Alzheimer’s Plaques Co-Accumulate with Potential Biomarker or Target Proteins
News

Alzheimer’s Plaques Co-Accumulate with Potential Biomarker or Target Proteins

Alzheimer’s Disease Symptoms Lessened and Improved in Mice by Dopamine Treatment
Drug Discovery

Alzheimer’s Disease Symptoms Lessened and Improved in Mice by Dopamine Treatment

Alzheimer’s Treatment Leverages Natural Repair Mechanism
Drug Discovery

Alzheimer’s Treatment Leverages Natural Repair Mechanism

Alzheimer’s Therapies Could Target Aβ Production by Oligodendrocytes, Not Just Neurons
Drug Discovery

Alzheimer’s Therapies Could Target Aβ Production by Oligodendrocytes, Not Just Neurons

Parkinson’s Disease Aggregates Do Not Appear to Evolve from Protein Droplets
News

Parkinson’s Disease Aggregates Do Not Appear to Evolve from Protein Droplets

Deep Dive into Brain’s Molecular Structures Affected by Alzheimer’s Disease
News

Deep Dive into Brain’s Molecular Structures Affected by Alzheimer’s Disease

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s
Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Sex-Specific Parental History of Alzheimer’s Could Identify At-Risk Adults
Featured

Sex-Specific Parental History of Alzheimer’s Could Identify At-Risk Adults

123...14Page 1 of 14
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.